All4NutraNo products in the cart.
All4NutraStartseite » Solid Dispersion » Page 27
Most of the promising drugs in development channels are poorly water-soluble drugs which limit formulation approaches, clinical application because of...
Amorphous solid dispersions (ASDs) are regarded as one of the most promising techniques for poorly-soluble active pharmaceutical ingredients (API). However,...
Amorphous solid dispersion (ASD) dosage forms can improve the oral bioavailability of poorly water-soluble drugs, enabling the commercialization of new...
In this series of webinars we will discuss the latest developments in the fields of amorphous solid dispersion (ASD) focusing...
For poorly soluble drugs formulated as amorphous solid dispersions (ASDs), fast and complete release with the generation of drug-rich colloidal...
Among many methods to mitigate the solubility limitations of drug compounds, amorphous solid dispersion (ASD) is considered to be one...
The bioavailability of insoluble crystalline active pharmaceutical ingredients (APIs) can be enhanced by formulation as amorphous solid dispersions (ASDs). One...
Solid dispersions (SDs) are one of the successfully applied methods to improve the solubility and dissolution rates of poorly water-soluble...
This research demonstrates the influence of laser speed and the drug particle size on the manufacturing of amorphous solid dispersions...
Amorphous solid dispersions can improve the solubility and dissolution rate of poorly soluble drugs. However, residual crystallinity can adversely affect...
Copyright: PharmaExcipients AG